Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Q. I am dealing with a horrible decline from generic Wellbutrin XL. I’ve been on samples of the name brand and my symptoms slowly improved. The generic is definitely a problem. My insurance won’t ...

6.0.428 [C:\Program Files\dotnet\sdk] 8.0.413 [C:\Program Files\dotnet\sdk] 9.0.109 [C:\Program Files\dotnet\sdk] 9.0.306 [C:\Program Files\dotnet\sdk] If this is a report about a bug in an analyzer, ...

A new investigative report released by Senators Kirsten Gillibrand (D-NY) and Rick Scott (R-FL), ranking member and chairman of the US Senate Special Committee on Aging, respectively, details the ...

In December of 2007, LeRoy Hubley endured the most devastating experience of his life. His wife of 48 years and his son died within weeks of each other. The culprit? Contaminated doses of Chinese-made ...

WASHINGTON — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a second generic form of mifepristone. HHS is reportedly reviewing mifepristone after state ...

U.S President Donald Trump's move to impose 100% tariffs on patented, branded drugs are expected to have a limited impact on India's pharma industry. Most Indian drugmakers sell generic pharmaceutical ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic versions of Novo Nordisk’s lucrative semaglutide drugs for diabetes and obesity.

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...